Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor
Authors
Keywords
-
Journal
BMC CANCER
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-22
DOI
10.1186/s12885-019-5700-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multifunctional thiosemicarbazones and deconstructed analogues as a strategy to study the involvement of metal chelation, Sigma-2 (σ 2 ) receptor and P-gp protein in the cytotoxic action: In vitro and in vivo activity in pancreatic tumors
- (2018) Maria Laura Pati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity
- (2017) et al. MOLECULES
- Identification of the gene that codes for the σ2receptor
- (2017) Assaf Alon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adhesion- and stress-related adaptation of glioma radiochemoresistance is circumvented by β1 integrin/JNK co-targeting
- (2017) Anne Vehlow et al. Oncotarget
- A Feasibility Study of Personalized Prescription Schemes for Glioblastoma Patients Using a Proliferation and Invasion Glioma Model
- (2017) Minsun Kim et al. Cancers
- Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity
- (2016) Angela Di Capua et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent advances and future of immunotherapy for glioblastoma
- (2016) Neha Kamran et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Pharmacotherapies for the treatment of glioblastoma – current evidence and perspectives
- (2016) Katharina Seystahl et al. EXPERT OPINION ON PHARMACOTHERAPY
- Novel and Selective Fluorescent σ2-Receptor Ligand with a 3,4-Dihydroisoquinolin-1-one Scaffold: A Tool to Study σ2Receptors in Living Cells
- (2015) Mauro Niso et al. CHEMBIOCHEM
- RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells
- (2015) Guanzhong Qiu et al. TUMOR BIOLOGY
- Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ2 receptors
- (2013) Carmen Abate et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Sigma-2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy
- (2013) Yun-Sheng Huang et al. MEDICINAL RESEARCH REVIEWS
- Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
- (2013) María P. Torres et al. PLoS One
- Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer
- (2012) John R Hornick et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Fluorescent Derivatives of σ Receptor Ligand 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) as a Tool for Uptake and Cellular Localization Studies in Pancreatic Tumor Cells
- (2011) Carmen Abate et al. JOURNAL OF MEDICINAL CHEMISTRY
- Analogues of σ Receptor Ligand 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with Added Polar Functionality and Reduced Lipophilicity for Potential Use as Positron Emission Tomography Radiotracers
- (2011) Carmen Abate et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tumor-secreted SDF-1 promotes glioma invasiveness and TAM tropism toward hypoxia in a murine astrocytoma model
- (2011) Shu-Chi Wang et al. LABORATORY INVESTIGATION
- Early development of sigma-receptor ligands
- (2010) Sanju Narayanan et al. Future Medicinal Chemistry
- The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine
- (2010) John R Hornick et al. Molecular Cancer
- Exploring the Importance of Piperazine N-Atoms for σ2Receptor Affinity and Activity in a Series of Analogs of 1-Cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28)†
- (2009) Francesco Berardi et al. JOURNAL OF MEDICINAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started